Healthcare technology – Hospice Of Howard County http://hospiceofhowardcounty.com/ Fri, 14 Jan 2022 20:33:17 +0000 en-US hourly 1 https://wordpress.org/?v=5.8 https://hospiceofhowardcounty.com/wp-content/uploads/2021/10/cropped-icon-32x32.png Healthcare technology – Hospice Of Howard County http://hospiceofhowardcounty.com/ 32 32 MobiDev lists the top 6 health tech trends in 2022 https://hospiceofhowardcounty.com/mobidev-lists-the-top-6-health-tech-trends-in-2022/ Fri, 14 Jan 2022 09:00:00 +0000 https://hospiceofhowardcounty.com/mobidev-lists-the-top-6-health-tech-trends-in-2022/ As 2022 dawns, the presence of COVID-19 continues to persist around the world. That being said, it is essential to stay alert to the technology trends that are driving digital transformation. MobiDev experts list the most important health technology trends that will impact the industry in 2022. Trend 1: Artificial Intelligence in Healthcare In the […]]]>

As 2022 dawns, the presence of COVID-19 continues to persist around the world. That being said, it is essential to stay alert to the technology trends that are driving digital transformation. MobiDev experts list the most important health technology trends that will impact the industry in 2022.

Trend 1: Artificial Intelligence in Healthcare

In the healthcare industry, machine learning is extremely useful for the development of new pharmaceutical products and the efficiency of diagnostic processes. AI helps analyze CT scans to detect pneumonia. Microsoft has developed InnerEye Project, a radiotherapy AI tool. By analyzing 100,000 media sources daily in over 65 different languages, an app called BlueDot can see dangerous outbreaks in near real time. Mentioning mental health, the researchers from MIT and Harvard University used machine learning to track trends and mental health correlating to the COVID-19 pandemic.

Trend 2: Telemedicine

In 2022, healthcare providers are holding regular videoconference meetings with patients over the internet to discuss their concerns and provide advice. The infrastructure to support this has improved significantly. Telehealth is expected to reach $185.6 billion by 2026. If you need a dedicated telemedicine application, one of the most important technologies that will be needed is WebRTC, an open-source API-based system that connects web browsers and mobile apps and allows audio, video, and data to be transmitted.

Trend 3: Extended Reality

From assistance with surgery to assistance with telehealth applications, AR and VR technologies can greatly improve the health industry. One of the most popular and useful forms of this technology is the use of mixed reality headsets like Microsoft Hololens 2 by surgeons. The helmet can provide warning information to the surgeon while allowing him to use both hands during the procedure. Not only can these surgeries be enriched with this head-up information, but it can be a collaborative, remote effort and help for training purposes.

Trend 4: IoT

The global IoT medical device market is projected to reach $94.2 billion by 2026 from $26.5 billion in 2021. One of the most profound applications of IoT technology in healthcare is the smart pill concept, which turns the Internet of Things into The internet of bodies. Smart pills are edible electronic products that not only serve as pharmaceuticals, but can also provide healthcare providers with valuable patient information. With the healthcare sector becoming increasingly connected through these technologies, the IoT cannot be ignored.

Trend 5: Privacy and Security

Ensuring your organization is HIPAA compliant is an essential first step in avoiding costly data breaches. If you serve patients internationally, it may be a good idea to consider the regulations of the General Data Protection Regulation (GDPR) in the European Union.

Trend 6: Organ care and bio-printing

With the global transplant market size expected to reach $26.5 billion by 2028, organ transplants are certainly an important part of the healthcare industry. The organ care system developed by Transmedics is an excellent example. This device can keep a heart, lung, or liver outside the body for several hours with proper care, heat, and the supply of important nutrients. Bio-printing was done in the past but has not yet reached the general public. It is possible that through AI analysis of organs and recipient patient characteristics, organs can be better designed to be compatible with their new hosts.

More detailed information on health technology trends in 2022 can be found on the MobiDev site here.

MobiDev is a Ukrainian-American software engineering company that helps visionaries create their products. The company invests inat technology research and has years of experience building AI-based solutions, implementing machine learning, augmented reality and IoT.

]]>
The Tuesday sector laggards: healthcare, technology and communications https://hospiceofhowardcounty.com/the-tuesday-sector-laggards-healthcare-technology-and-communications/ Tue, 04 Jan 2022 19:31:20 +0000 https://hospiceofhowardcounty.com/the-tuesday-sector-laggards-healthcare-technology-and-communications/ TThe worst performing sector Tuesday at noon is the health sector, posting a loss of 1.5%. Within the sector, Charles River Laboratories International Inc. (Ticker: CRL) and PerkinElmer, Inc. (Ticker: PKI) are two large stocks that are lagging behind, posting a loss of 5.6% and 5.6%, respectively. Among ETF health, the ETF next to the […]]]>

TThe worst performing sector Tuesday at noon is the health sector, posting a loss of 1.5%. Within the sector, Charles River Laboratories International Inc. (Ticker: CRL) and PerkinElmer, Inc. (Ticker: PKI) are two large stocks that are lagging behind, posting a loss of 5.6% and 5.6%, respectively. Among ETF health, the ETF next to the sector is the Health Care Select Sector SPDR ETF (ticker: XLV), which is down 1.6% on the day and 2.58% year-to-date. Charles River Laboratories International Inc., meanwhile, is down 9.25% year-to-date, and PerkinElmer, Inc., 9.76% year-to-date. Together, CRLs and PKIs represent approximately 0.8% of XLV’s underlying holdings.

The second worst performing sector is the technology and communications sector, posting a loss of 1.3%. Among large tech and communications stocks, ServiceNow Inc (ticker: NOW) and Enphase Energy Inc. (ticker: ENPH) are the most notable, posting losses of 8.1% and 6.2%, respectively. The Technology Select Sector SPDR ETF (XLK), which closely tracks technology and communications stocks, is down 1.7% at midday and 0.76% year-to-date. year. ServiceNow Inc, meanwhile, is down 10.74% year-to-date, and Enphase Energy Inc., 5.40% year-to-date. Together, NOW and ENPH represent approximately 1.3% of the underlying holdings of XLK.

Comparing these stocks and ETFs on a rolling twelve month basis, below is a chart of relative stock price performance, with each of the symbols displayed in a different color, as shown in the legend at the bottom:

Here’s a look at how the components of the S&P 500 have moved across sectors in Tuesday afternoon trading. As you can see, seven sectors are up on this day while two sectors are down.

Sector % Change
Energy + 3.8%
Financial + 2.0%
Consumer products + 1.8%
Materials + 1.6%
Industrial + 1.3%
Services + 0.3%
Utilities + 0.3%
Technology and communication -1.3%
Health care -1.5%

10 ETFs with stocks that insiders buy »

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


Source link

]]>
NetApp and Narayana Health Develop “Athma” Patient Registration System, Health News, ET HealthWorld https://hospiceofhowardcounty.com/netapp-and-narayana-health-develop-athma-patient-registration-system-health-news-et-healthworld/ Thu, 23 Dec 2021 09:24:00 +0000 https://hospiceofhowardcounty.com/netapp-and-narayana-health-develop-athma-patient-registration-system-health-news-et-healthworld/ Bangalore: Narayana Health, in collaboration with software publisher NetApp, unveiled an “Athma” case management system that will allow the company to manage its health data in a secure and efficient manner. NetApp will work with Narayana to modernize its IT systems and implement technological advancements in healthcare management to improve patient care services. The healthcare […]]]>
Bangalore: Narayana Health, in collaboration with software publisher NetApp, unveiled an “Athma” case management system that will allow the company to manage its health data in a secure and efficient manner. NetApp will work with Narayana to modernize its IT systems and implement technological advancements in healthcare management to improve patient care services.

The healthcare provider intends to build a responsive IT infrastructure for faster diagnosis and shorter response times, thus making the process easier for patients and physicians. To achieve this goal, Narayana Health deployed NetApp technology solutions to develop a patient management system capable of storing and processing patient records. The resulting Athma system can capture, store, and retrieve networks at 15 sites to produce the required information. The system allows medical staff and patients to access their entire medical history in a short period of time, further improving the quality of health services provided by Narayana.

Elaborating on the inculcation of technology to advance healthcare services, Ramu Manjunath, Head of Core Infrastructure, Narayana Health, said, “NetApp offers a unique approach to data management. Data storage on NetApp is much faster compared to other solution providers. He offered simple and easy infrastructure management solutions to our engineers. The whole move to NetApp has been fairly straightforward and transparent from an implementation, architecture, and support perspective. With Athma, patients have complete continuity of all their medical history. Their history is available in our system and can be retrieved in seconds, so physicians can review and take a call rather than going back and forth to find cases or reinvest in investigations.

The collaboration aims to optimize the efficiency of data storage and management across all locations, helping to advance healthcare in India. The Athma centralized data and application storage system is based on NetApp and is available in the cloud. NetApp Cloud Volumes ONTAP software makes it easy to manage stored data. Two fully replicated data centers, one in Central India and one in South India, perform backup and restore using Azure NetApp Files and NetApp File Services . The system provides clinical staff with essential and timely information that further enables them to provide better patient care.

Speaking about the positive impact the collaboration aims to bring, Puneet Gupta, Managing Director and Vice President India / SAARC, NetApp India Marketing and Services, said, “Simplicity is at the heart of everything we do at NetApp. Our solutions are designed to be easy to implement and scalable. For next-generation healthcare providers, accessibility to data and health records is of paramount importance today. With our heritage and experience in data management, and our core technology offerings, we are happy to contribute to the changing landscape of healthcare in India. It is an accomplishment to see that our solutions directly enable physicians to provide better medical care to the needy.

The Narayana Health hospital system plans to increase the number of locations and add more clinical services in more than 60 specialties. with the help of NetApp. Cloud Volumes ONTAP will provide tools such as NetApp Active IQ® Digital Advisor to help the hospital manage and optimize costs.


Source link

]]>
TrialAssure LINK Wins Gold Globee® for Healthcare Technology Solution at 2021 International Best in Business Awards https://hospiceofhowardcounty.com/trialassure-link-wins-gold-globee-for-healthcare-technology-solution-at-2021-international-best-in-business-awards/ Tue, 21 Dec 2021 14:01:00 +0000 https://hospiceofhowardcounty.com/trialassure-link-wins-gold-globee-for-healthcare-technology-solution-at-2021-international-best-in-business-awards/ TOWNSHIP, Michigan – (COMMERCIAL THREAD) – TrialAssure, a leading global provider advancing clinical trial disclosure, data sharing and transparency, announces that the Globee® Price named TrialAssure LINK as the winner for the healthcare technology solution in the 8e 2021 Annual International Awards for Best in Business. TrialAssure LINK uses advanced process automation techniques to facilitate […]]]>

TOWNSHIP, Michigan – (COMMERCIAL THREAD) – TrialAssure, a leading global provider advancing clinical trial disclosure, data sharing and transparency, announces that the Globee® Price named TrialAssure LINK as the winner for the healthcare technology solution in the 8e 2021 Annual International Awards for Best in Business.

TrialAssure LINK uses advanced process automation techniques to facilitate the efficient development, review, translation and publication of plain language and lay language summaries. TrialAssure LINK cuts the process of writing plain language abstracts from scratch by more than four weeks, enabling sponsors to meet increasing compliance requirements and improving access to information for trial participants.

Industry experts from around the world participated in the assessment process and recognized the innovations of individuals and teams who have set benchmarks of excellence in the industry.

“Increasing clinical trial participants’ access to information through data sharing and transparency is important to us and our sponsors,” said Mohamad Zahreddine, Chief Information Officer, TrialAssure. “We are proud to be recognized as a technological healthcare solution by the Globee® Awards and I think this further confirms that the key features of TrialAssure LINK are breaking new ground in the healthcare industry.

Other applications in TrialAssure’s Ultimate Transparency Suite include TrialAssure REGISTRY, TrialAssure ANONYMIZE, and TrialAssure BEACON.

To request a LINK demo, go to www.trialassure.com/demo/ or by email at info@trialassure.com

ABOUT TrialAssure

TrialAssure is a leading global provider of clinical trial disclosure and data transparency with unmatched experience to help overcome the complex challenges of regulatory compliance. TrialAssure provides fast, affordable and intelligent software and service solutions to facilitate clinical trial disclosure (recording and reporting of results), document and data anonymization, and increased patient engagement, while providing deliverables of transparency of the highest quality clinical trials that exceed the most stringent requirements. Established in 2009, TrialAssure regularly adapts to the ever-changing requirements of clinical trial disclosure and data transparency and was named Data Solution of the Year – Healthcare in the Data Breakthrough Awards. For more information visit www.trialassure.com or follow TrialAssure on LinkedIn.

ABOUT the Globee Awards

The Globee Awards are presented in eleven programs and competitions: the American Best in Business Awards, the Business Excellence Awards (Best Employers), the CEO World Awards®, Communications Excellence Awards, Cyber ​​Security Global Excellence Awards®, Disruptor Company Awards, Golden Bridge Awards®, International Best in Business Awards, IT World Awards®, Sales, Marketing and Service Excellence Award and Women World Awards®. Find out more about the Globee Awards at https://globeeawards.com


Source link

]]>
Oracle to acquire healthcare tech giant Cerner for $ 28.3 billion https://hospiceofhowardcounty.com/oracle-to-acquire-healthcare-tech-giant-cerner-for-28-3-billion/ Mon, 20 Dec 2021 18:34:09 +0000 https://hospiceofhowardcounty.com/oracle-to-acquire-healthcare-tech-giant-cerner-for-28-3-billion/ Confirming recent reports, Oracle Corp. today announcement that it has entered into a deal to acquire healthcare technology provider Cerner Corp. for approximately $ 28.3 billion. Oracle’s $ 28.3 billion offer is about $ 95 per share. Cerner’s stock is up nearly 1% in trading today, while Oracle’s is down more than 4%. Kansas City-based […]]]>

Confirming recent reports, Oracle Corp. today announcement that it has entered into a deal to acquire healthcare technology provider Cerner Corp. for approximately $ 28.3 billion.

Oracle’s $ 28.3 billion offer is about $ 95 per share. Cerner’s stock is up nearly 1% in trading today, while Oracle’s is down more than 4%.

Kansas City-based Cerner provides electronic health record software, or EHR, that healthcare organizations such as hospitals use to manage patient medical data. The company is a major player in the EHR market, with sales of $ 5.5 billion last year. Cerner also offers a range of specialized applications in addition to its EHR software that are used by hospitals to manage care delivery, perform business administration tasks, and analyze operational data to find ways to increase efficiency. efficiency.

Oracle has big plans for the acquisition. The database maker said it will integrate its Voice Digital Assistant product with Cerner’s software to help healthcare professionals access patient data faster.

In developing, Oracle Executive Chairman and CTO Larry Ellison said the company aims to “provide our overworked healthcare professionals with a new generation of easier-to-use digital tools that enable ” access information through a hands-free voice interface to secure cloud applications.

Oracle believes there is an opportunity to help healthcare organizations run more efficiently and thereby improve patient care. “This new generation of medical information systems promises to reduce the administrative workload on our healthcare professionals, improve patient privacy and outcomes, and lower overall healthcare costs,” said Ellison.

As part of Cerner’s software improvement plan, Oracle will move systems from software maker EHR to its public cloud platform. “This can be done very quickly because Cerner’s largest company and largest clinical system is already running on the Oracle database,” said Mike Sicilia, executive vice president of Vertical Industries at Oracle.

The plan, the companies said today, is for Cerner to use Oracle’s infrastructure and cloud resources to accelerate the pace of product development initiatives. Oracle highlighted its artificial intelligence capabilities as another asset that can help Cerner customers operate more efficiently.

On the business side, Oracle plans to make Cerner a “huge driver of additional revenue growth” for years to come. In his most recent quarterly results report, Cerner reported a 7% year-over-year increase in revenue, which helped boost sales to $ 1.36 billion. Oracle intends to accelerate the growth rate of the EHR software vendor by offering its products in more countries.

“This is exactly the growth strategy we adopted when we bought NetSuite, except that Cerner’s revenue opportunity is even greater,” said Safra Catz, CEO of Oracle. NetSuite Inc. is a maker of commercial applications that Oracle acquired in 2016 for $ 9.3 billion. The deal was the second largest acquisition in the company’s history until that point.

“Oracle’s acquisition of Cerner may be a way to gain a solid foothold in the emerging healthcare cloud opportunity,” commented Paddy Padmanabhan, Founder and CEO of Damo Consulting, a growth strategy company and digital transformation that works with healthcare organizations as well as technology. companies. “Cerner is a leading provider of EHRs and healthcare is in the early stages of moving to the cloud. “

Oracle hopes to complete the acquisition next year. The company’s proposed acquisition of Cerner is the second major healthcare purchase made by a leading technology company this year. Previously, Microsoft Corp. $ 19.7 billion deal to acquire Nuance Communications Inc., whose medical note dictation software is used by a significant percentage doctors in the United States

The acquisitions continue a broader trend of leading enterprise technology providers to focus more on vertical industries.

Last year, Salesforce.com Inc. introduced a range of vertical specific solutions called Industry Clouds. Industry Clouds combine functionality from the company’s existing products with niche capabilities for specific industries. Most recently, in September, Snowflake Inc. introduced a vertical specific solution designed for companies in the financial sector.

Vertical industries have also become a priority among major public cloud operators. Amazon Web Services Inc. this year introduced Amazon FinSpace, a data processing service for the financial industry. Google LLC’s cloud activity in July debuted Healthcare Data Engine, a solution that facilitates the processing of medical data by healthcare establishments.

Oracle expects the Cerner’s acquisition to have an immediate impact on its adjusted earnings in the first full fiscal year after closing. The $ 28.3 billion offered by Oracle is a significant premium over the roughly $ 23 billion that Cerner has value last week, before reports on the acquisition were first released. The high premium underscores the key role Cerner sees in Oracle’s growth plans.

“Cerner has been a leader in helping digitize healthcare and now is the time to deliver on the true promise of this work with healthcare delivery tools that get information to the right caregivers at the right time,” said the President and CEO of Cerner, David Feinberg. “Joining Oracle as a dedicated industry business unit provides an unprecedented opportunity to accelerate our work of modernizing electronic health records, improving the caregiver experience, and creating more connected patient care. , high quality and efficient. ”

Photo: Open Grid Scheduler / Grid Engine / Flickr

Show your support for our mission by joining our community of Cube Club and Cube Event experts. Join the community which includes Amazon Web Services and Amazon.com CEO Andy Jassy, ​​Dell Technologies Founder and CEO Michael Dell, Intel CEO Pat Gelsinger and many other luminaries and experts.


Source link

]]>
Healthlane announces preventive healthcare technology https://hospiceofhowardcounty.com/healthlane-announces-preventive-healthcare-technology/ Mon, 13 Dec 2021 11:06:22 +0000 https://hospiceofhowardcounty.com/healthlane-announces-preventive-healthcare-technology/ The Healthlane app allows users to make doctor appointments, view medical test results and records, view health score, access care plan and nutritional advice. Healthlane, a global preventive healthcare provider has opened its Lagos facility in Lekki, Lagos. Healthlane offers comprehensive wellness checkups and personalized care plans that make it easy to understand, monitor and […]]]>

The Healthlane app allows users to make doctor appointments, view medical test results and records, view health score, access care plan and nutritional advice.


Healthlane, a global preventive healthcare provider has opened its Lagos facility in Lekki, Lagos.

Healthlane offers comprehensive wellness checkups and personalized care plans that make it easy to understand, monitor and improve your health. With the Healthlane app, users can book for comprehensive world-class checkups, view medical test results and records, view health scores, and get a comprehensive care plan for nutrition, exercise, sleep and supplements.

From left to right: Buchi Okereke, guest speaker; Alain Nteff, CEO of Healthlane;
Damola Ajayi, Sales Manager at Healthlane; Lincoln Saiki, MD
at Healthlane; Nadayar Enegesi, guest speaker; Karen Onigbinde, Head of
Produced at Healthlane

Speaking at the press conference in Lagos, Healthlane CEO Mr. Alain Nteff said “Our mission is to simplify the way people understand, track and improve their health; enable longer and healthier lives and reduce reliance on an overburdened primary health care system. “

He further clarified that health care has been confused with health care. The first sees a doctor after feeling sick and experiencing symptoms while the second (health care) is about nutrition, exercise, supplements, lifestyle and check-ups. The goal of Healthlane is to prevent people from getting sick and to enable them to live longer and healthier lives.

He further states that now is the right time for the brand to jump into the healthcare industry seeing how the Covid-19 pandemic has accelerated the digitalization of different industries.

“Today, people are now comfortable accessing their medical records on their smartphones. They are more concerned with preventing themselves so as not to fall prey to certain diseases. We all know that if you have diabetes or have high blood pressure, you are more affected if you contract Covid-19 compared to someone who is relatively healthy. There is a growing trend to deploy services through technology and this is where we have positioned ourselves ”, Nteff says.

As a customer-centric brand, Healthlane’s experience is convenient and seamless. With professional doctors, the results are fully explained to clients while a personalized care plan is immediately available on the Healthlane app. This ensures that by the time clients leave the facility, they have a good understanding of their condition and what they need to do to improve it.

Healthlane has developed a world class lab in its Lekki office and is also able to easily set up in corporate workplaces. Healthlane is partnering with insurance companies and HMOs as the company moves to shift the continent and the world to a new horizon for employers and employees.

Speaking more about Healthlane’s desire to make it easier to access preventive health care, Mr Nteff says, “A lot of our target audience is registered on an HMO and those who don’t pay an out-of-court fee to do all of this. tests and get results. within a maximum waiting time of 45 minutes. We are the new medical tourism destination and are happy to do our part to improve a situation that many would rather complain about. “


About Healthlane

Healthlane’s mission is to provide everyone with access to world-class preventive health care, leading to longer and healthier lives. Healthlane’s vision is to bring all preventive and primary health care needs from the comfort of home and mobile. Healthlane leverages the smart and creative technology and solutions that currently exist to forge a path into the future they envision for generations to come.

Healthlane Office: 16, Adewale Kolawole Crescent, Lekki Marwa, Lagos

E-mail: support@healthlane.co

Get the best African tech newsletters delivered to your inbox


Source link

]]>
How health technology can (believe it or not) humanize medicine https://hospiceofhowardcounty.com/how-health-technology-can-believe-it-or-not-humanize-medicine/ Thu, 09 Dec 2021 08:00:00 +0000 https://hospiceofhowardcounty.com/how-health-technology-can-believe-it-or-not-humanize-medicine/ At first glance, it seems incongruous: Can healthcare technology humanize healthcare? But how? Wouldn’t the contrary be true? Wouldn’t tech’s foray into this sector make medicine more impersonal? Wouldn’t the use of telehealth platforms, which became more frequent during the pandemic, put more distance than ever between the provider and the patient? Not really. The […]]]>

At first glance, it seems incongruous: Can healthcare technology humanize healthcare? But how? Wouldn’t the contrary be true? Wouldn’t tech’s foray into this sector make medicine more impersonal? Wouldn’t the use of telehealth platforms, which became more frequent during the pandemic, put more distance than ever between the provider and the patient?

Not really. The argument now is that technology allows for an ever greater connection, a constant and cohesive connection. As a Deloitte team put it in a February 2020 article on the Modern Healthcare website:

“(Virtual care) works in and around a patient’s life, as opposed to their illness, to provide care when, where and how they need and want it. In addition, virtual health is making its way into the daily routines of consumers by being incorporated into electronic devices associated with life (eg, smartphones and personal computers) rather than care for disease. “

One of the members of this Deloitte team is Summer Knight, the organization’s Managing Director in Life Sciences and Healthcare Consulting. In her book “Humanizing Healthcare: Hardwire Humanity into the Future of Health”, she convincingly argues that technology bridges the gap between patients and healthcare professionals. In fact, she believes more technology, not less, is crucial to humanizing the industry.

She made this point clear on the Finding Genius podcast in early summer 2021. Knight mentioned that a digital healthcare activation platform would “bring” patients and providers together, and provide “a point. ‘tangible connection’ that a visit to a doctor’s office cannot. In addition, she specifies, such technology creates a “therapeutic alliance” between the consumer, his support system and the healthcare team.

There is ample indication that it is on the money. The Deloitte team noted that long before the pandemic – all the way back in 2016, in fact – spending in the virtual health market is expected to reach $ 3.5 billion by 2022.

The epidemic changed the situation dramatically, as seven in 10 Americans were suspicious of doctor’s office visits and embraced virtual care. These visits represented 70% of appointments in the first months of the crisis (compared to 8% previously). This is a promising development, as patients had long discovered that while virtual appointments were shorter, they allowed for greater interaction with physicians, as well as more direct involvement of consumers in their own care.

Studies have shown that telehealth visits have become much less frequent in the last few months of 2020, dropping to 30% of all appointments, but it’s clear nonetheless that the technology is being built into the healthcare system. Consider, for example, the use of bedside tablets. Before the outbreak, they were first used by residents for entertainment and relaxation, but became a vital communication link with loved ones when government-imposed closures were instituted.

Richard Mohnk, associate IT director for operations at Bayhealth, told Becker’s Hospital Review that such tablets have proven to be a “game changer” in his facility, and while Steven Smith, IT director at NorthShore University HealthSystem, does ‘would not go that far, he told the same outlet that “adjusting procedures and providing this functionality so quickly during the pandemic … has helped preserve and improve human life.”

Technology can only be expected to continue to evolve, to address a physician shortage and to meet the needs of an aging population in the years to come. According to a new report from the Association of American Medical Colleges, the U.S. population, which stood at 328 million in 2019, is expected to reach 363 million by 2034, an increase of 10.6%. However, the population aged 65 and over is expected to increase by 42.4%.

This same report indicates that there will be a shortage of 37,800 to 124,000 physicians by the same year. In other words, there will almost certainly be more people with chronic illnesses and fewer people to care for them.

But time-saving (not to mention life-saving) gadgets can be expected to fill the gap, while also improving the connections mentioned above. The Harvard Business Review, for example, believes that the technology is able to achieve the latter goal by being friendly to patients and providers, actively engaging all parties, and offering factual information.

Understand that healthcare technology has often been viewed with suspicion. Throughout the 1700s, there were concerns that the stethoscope would strain the bonds between doctor and patient. But those concerns were unfounded then, and they are now. When used correctly, technology, far from breaking these bonds, only strengthens them and improves the patient experience.

]]>
North America Dominates Healthcare Nanotechnology for Active Implantable Devices During Review Period: Fact.MR https://hospiceofhowardcounty.com/north-america-dominates-healthcare-nanotechnology-for-active-implantable-devices-during-review-period-fact-mr/ Wed, 08 Dec 2021 19:22:00 +0000 https://hospiceofhowardcounty.com/north-america-dominates-healthcare-nanotechnology-for-active-implantable-devices-during-review-period-fact-mr/ Nano-Health Technology Competition Market Forecast, Trends, Analysis and Tracking – Global Market Snapshot 2020 to 2030 UNITED STATES, December 9, 2021 /EINPresswire.com/ – Growing demand for advanced and efficient equipment and supportive government initiatives are expected to boost the healthcare nanotechnology market, Fact.MR finds in a new study. The increase in the geriatric population as […]]]>

Nano-Health Technology Competition Market Forecast, Trends, Analysis and Tracking – Global Market Snapshot 2020 to 2030

UNITED STATES, December 9, 2021 /EINPresswire.com/ – Growing demand for advanced and efficient equipment and supportive government initiatives are expected to boost the healthcare nanotechnology market, Fact.MR finds in a new study. The increase in the geriatric population as well as the developments in the healthcare sector are the main drivers of the market. The increase in government initiatives and investments are the main factors driving the adoption of nanotechnology in healthcare.

The advent of nanotechnology has helped improve and improve various healthcare systems and creates opportunities to transform various processes within the healthcare industry, including diagnosis, treatment, drug delivery and others. The integration of nanotechnology into monitoring devices, imaging and biological tests ensures better precision in the diagnosis of diseases.

There has been an increasing adoption of nanotechnology in the treatment of chronic diseases. It finds application in biochips, implantable materials and medical textiles, and dressings. The growing number of patients affected by COVID-19 has also affected the growth of the market.

Request a Sample Report for Complete Market Information on https://www.factmr.com/connectus/sample?flag=S&rep_id=5430

Key takeaways from the Nano Healthcare Technology Market report
• There has been an increase in the adoption of biochips to improve disease diagnosis, which contributes to the increase in sales in the health nanotechnology market.
• High costs and complex product approval procedures, however, may restrict demand to some extent.
• North America will become a dominant market as the region displays high investments in modern healthcare. Asia-Pacific will also provide lucrative growth opportunities throughout the forecast period
• The demand for active implantable devices is set to increase exponentially in the coming years, creating exciting growth opportunities.
• In the coming years, the therapeutic application of nanotechnology in healthcare will increase dramatically, Fact MR finds in study

“The demand for advanced treatment processes will continue to increase as the healthcare industry witnesses an increase in the incidence of chronic disease. Technological improvements are in high demand, now more than ever before, especially as countries around the world try to contain the spread of the new coronavirus. Nanotechnology is believed to have the potential to enable early detection of COVIDF-19 even before a patient begins to show symptoms. In the coming years, its penetration into the healthcare industry is expected to increase significantly, ”said a senior analyst at Fact MR.

Customization request: https://www.factmr.com/connectus/sample?flag=AE&rep_id=5430

Impact of COVID-19 on the health nanotechnology market
• The COVID-19 pandemic has disrupted several industries, including the health nanotechnology market. The implementation of containment and transport bans affected the production of equipment. But the growing number of patients has positively impacted the demand for nanotechnology-based devices.

• The market is expected to recover from the pandemic at a moderate growth rate. Growing health caution is expected to increase the use of nanotechnology-based devices in the healthcare industry.

• Competitive landscape of the health nanotechnology market
• Players operating in the market are now focusing on research and development of nanotechnology to improve its efficiency in various applications. Developments underway to improve drug delivery and ensure better diagnostic accuracy.

• Nanotechnology is now being used to develop smart pills that will increase the effectiveness of treatment. Special nano-robots are also introduced to assist and perform various surgical procedures. There have been great concerns about the side effects and shortcomings of using nanotechnology due to the less research being conducted. Players strive to dispel these doubts by increasing experimentation and research.

• For example, researchers at the Massachusetts Institute of Technology, Draper, and Brigham and Women’s Hospital unveiled the design of an ingestible capsule that can be controlled using wireless technology – Bluetooth. The design of this capsule can be customized to sense environmental conditions, deliver drugs and live in the stomach for nearly a month, relaying information to users and responding to instructions they share through smartphones.

Buy now: https://www.factmr.com/checkout/5430

Some of the major players in the healthcare nanotechnology market are
• 3M Company
• Thermo Fisher Scientific Inc.
• Smith & Nephew Plc.
• GE Global Research
• Greiner Bio One International GmbH
• Dentsply Sirona
• Ferro Company
• Boston Scientific Society
• Sonova
• LivaNova Plc.
• Abbott Laboratories
• Stryker Company
• Merck KGaA
• Dismantling A / S
• Eppendorf AG
• Medtronic
• Cochlear Ltd.

Key Questions Answered In Fact.MR’s Report On The Healthcare Nanotechnology Market
• Which regions will remain the most profitable regional markets for players in the health nanotechnology market?
• What factors will induce a change in the demand for nanotechnology in healthcare during the evaluation period?
• How will changing trends impact the health nanotechnology market?
• How can market players seize the opportunities at hand in the health nanotechnology market in developed regions?
• Which companies dominate the health nanotechnology market?
• What are the winning strategies of players in the health nanotechnology market to gain strength in this landscape?

Valuable insights into the Nano-Health Technologies Market report
In its latest report, Fact.MR presented a detailed analysis of the healthcare nanotechnology market along with an assessment for the years 2020-2030. In order to provide a better understanding, the market has been divided into several segments.

The market has been segmented by product into biochips, implantable materials, medical textiles and dressings, active implantable devices and others. On the basis of applications, the market has been divided into therapeutic applications, diagnostic applications, and research applications. The market is segmented on the basis of geography as North America, Latin America, Europe, East Asia, South Asia, Oceania, Middle East and Africa.

Explore Fact.MR’s healthcare coverage

• Laboratory-Scale Bioreactor Competition Market Forecast, Trends, Analysis and Tracking – Global Market Snapshot 2021 to 2031: https://www.factmr.com/report/lab-scale-bioreactors-market

• Migraine Dual Treatment Market Forecast, Trend Analysis and Competition Tracking – Global Review 2021 to 2031: https://www.factmr.com/report/dual-migraine-treatment-market

• Calprotectin Serum Immunoassay Market Forecast, Trend Analysis and Competition Tracking – Global Review 2021 to 2031: https://www.factmr.com/report/calprotectin-serum-immunoassay-market

About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1000 companies trust us to make their most critical decisions. While our experienced consultants use the latest technology to extract hard-to-find information, we believe our USP is the trust clients have in our expertise. Covering a wide spectrum – from Automotive and Industry 4.0 to Healthcare and Retail, our coverage is broad, but we make sure that even the most specialized categories are analyzed. Our sales offices in the United States and in Dublin, Ireland. Headquarters based in Dubai, United Arab Emirates. Contact us with your goals, and we will be a competent research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Office 400
Rockville, Maryland 20852
United States
Phone. : +1 (628) 251-1583

The head office:
Unit number: AU-01-H Gold Tower (AU),
Plot number: JLT-PH1-I3A,
Jumeirah Lakes Tours,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit our website: https://www.factmr.com

Supriya bhor
RESEARCH AND ADVISORY SERVICES
+91 9922699448
write us here


Source link

]]>
AI in health technology: takeaways from our half-hour webinar on the power of patents https://hospiceofhowardcounty.com/ai-in-health-technology-takeaways-from-our-half-hour-webinar-on-the-power-of-patents/ Wed, 08 Dec 2021 08:00:00 +0000 https://hospiceofhowardcounty.com/ai-in-health-technology-takeaways-from-our-half-hour-webinar-on-the-power-of-patents/ Patent Power Half Hour is the supercharged, information-rich webinar series from Kilburn & Strode. We dive into typical EPO pitfalls and share practical tips on how to avoid them. All delivered in 30 minutes or less! Here’s a recap of the key takeaways from the webinar that took place on December 8, 2021, covering AI […]]]>

Patent Power Half Hour is the supercharged, information-rich webinar series from Kilburn & Strode. We dive into typical EPO pitfalls and share practical tips on how to avoid them. All delivered in 30 minutes or less!

Here’s a recap of the key takeaways from the webinar that took place on December 8, 2021, covering AI in healthcare. This webinar was a replay of our July webinar on MedTech Patents in Europe (Part 2).

Patenting AI innovation in MedTech

AI and machine learning have established themselves as essential tools in all areas of technology, and healthcare is no exception. In our condensed and information-rich Patent Power Half Hour, we shed the spotlight on two important topics: AI in drug discovery (whether or not you should patent AI innovation in this area) and criteria for obtaining patent protection at the EPO for AI Innovation Medtech (can you get patents in this area).

The answer to the first question may be, and the answer to the second question is clearly yes, if you can comply with the EPO’s examination guidelines. Read more below, but remember that while the EPO’s approach in this area is fairly established, there is always room to push the boundaries, so if you are considering borderline cases you can or maybe even should patent, enter contact us to discuss.

AI and drug discovery

In drug discovery, innovators have a strategic choice. Should you patent your AI-based drug discovery method? Or should you patent the product resulting from this method? Or both? There are a number of strategic advantages to focusing your patenting activity on pharmaceuticals, rather than the tools you use to identify them.

  1. Are you sure you want to disclose your AI method; maybe it is better to protect it as a trade secret? However, you may need to disclose your product on the way to regulatory approval.

  2. AI algorithms are often developed so quickly that the patent system is not ideal for protecting them; the patent application could become redundant too quickly. In contrast, your product is not as likely to change.

  3. Even if you get a complaint for your AI method, how will you know someone is breaking your complaint? It is easier to detect a violation of a product claim than a method claim.

  4. The EPO is developing a consistent and predictable approach to examining AI-related inventions. But the EPO’s pharmaceutical practice is even more established!

  5. You can claim a product without having to disclose the AI ​​/ ML method used in its development.

A key question for innovators in this field is whether they will need wet lab data to patent a pharmaceutical product in Europe. The sufficiency requirement of the claims for both pharmaceutical compositions and second medical use claims can be summarized as follows from T 1616/09:

For a pharmaceutical composition claim, the request must:

  1. Allow a person skilled in the art to produce the composition and

  2. Leave no doubt as to its use in therapy.

For a second medical use claim, the request must:

  1. Disclose composition in an enabling manner and

  2. plausibly disclose the suitability of the composition for the claimed treatment.

An application without wet lab data relying solely on AI-based predictions will have a difficult course to grant and may attract opposition after grant. If possible, create your new chemical entity or obtain clinical data to support your proposed reused drug. Then you can omit the AI ​​/ ML tool from your patent application.

The EPO’s approach to AI inventions: consistent and predictable

The EPO Guidelines make it clear that AI / ML is currently treated by the EPO as a mathematical method and that mathematical techniques such as AI / ML can contribute to technical character. There is a two-hurdle approach, described below, which gives applicants the tools they need to make a decision to file in Europe that they can have reasonable confidence in.

First of all: does the claimed object have a technical character as a whole? For that, you simply need “technical means”; in other words: a computer. Make sure that your complaint eliminates this obstacle by explicitly stating that the methods are “computer implemented” or by clearly defining a processor, server, device, network, and so on.

Second: does the mathematical method itself contribute to the technical character? Two alternative arguments have been developed in EPO case law that applicants can rely on to ensure that a mathematical method, for example an AI method, contributes to the technical character of an invention. The most relevant argument for AI methods in the MedTech sector concerns the technical application of the mathematical method. In summary, the EPO considers that an IA / ML or a mathematical method can contribute to the technical character of an invention due to its application to a specific technological field. During the prosecution, you will need to be able to argue that the method, in the context of the invention, serves a technical purpose. This technical purpose must be sufficiently specific. Examples from case law and review guidelines include enhancing or analyzing digital images (eg segmentation of medical images); providing medical diagnosis by an automated system processing physiological measurements; using a neural network in a cardiac monitoring device to identify an irregular heartbeat; and providing an estimate of the genotype based on analysis of samples DNA. In addition, the claim must be “functionally limited” to the technical objective. In other words, it is not enough to simply define a technical objective in the preamble of your application. Instead, the mathematical method should be sufficiently linked to the technical purpose, for example by ensuring that the claim defines the data processing that is relevant to the technical purpose, and that the resulting result clearly contributes to the technical purpose.

Of course, while applications that can overcome these obstacles should not expect EPO eligibility issues, this does not necessarily mean that applications that can not clear these obstacles do not stand a chance at the EPO. Contact us and we can give you a go / no-go assessment before filing in Europe. We love challenges!

Stronger, faster and cheaper patents in Europe

What action can you take now? You could:

  • Review and update your advice to US external lawyers regarding information to be included in AI requests when writing (e.g. technical application / purpose, types of claims)

  • Review and update invention entry forms for capture information on technical effects and everything is possible technical purposes

  • To consider co-drafting with a European lawyer to ensure that the correct language is included in the project

  • To consider pre-filing reviews and modifications before filing in Europe

  • Consider a go / no go evaluation to allow you to focus your resources on the cases that are most likely to be successful in Europe.


Source link

]]>
Laguna Health Adds Healthcare Technology Innovator Gil Kaminski as Vice President of Clinical Products https://hospiceofhowardcounty.com/laguna-health-adds-healthcare-technology-innovator-gil-kaminski-as-vice-president-of-clinical-products/ Tue, 07 Dec 2021 08:00:00 +0000 https://hospiceofhowardcounty.com/laguna-health-adds-healthcare-technology-innovator-gil-kaminski-as-vice-president-of-clinical-products/ Care transitions after outpatient surgery or hospitalization are costly when poorly managed, pose a great challenge for healthcare providers, and are an overwhelming and stressful experience for patients. In the United States, hospital readmissions account for 13% of business spending and 17% of Medicare spending. According to Bailey et al (2019) readmissions cost self-insured employers […]]]>

Care transitions after outpatient surgery or hospitalization are costly when poorly managed, pose a great challenge for healthcare providers, and are an overwhelming and stressful experience for patients. In the United States, hospital readmissions account for 13% of business spending and 17% of Medicare spending. According to Bailey et al (2019) readmissions cost self-insured employers 80 billion dollars annually, 50% of which is preventable. In addition, patients who are recovering from a health problem also navigate emotional, cognitive, financial, and psychological obstacles to recovery while learning to adjust to their recovery at home. Nutrition, exercise, socialization, activities of daily living are all important factors in a patient’s recovery. The myriad of factors and barriers to recovery are not a universal recovery formula for patients, which means that each patient has a different set of needs that affect their recovery.

Kaminski’s work allows Laguna to contextualize patient care, a process of identifying a patient’s individual circumstances to determine whether a patient’s care plan needs to be modified to reflect those circumstances. Contextualizing patient care is an integral part of Laguna’s tailored patient engagement model that will ensure a safer and more successful recovery process. As part of this effort, a comprehensive patient database is being built to design artificial and augmented intelligence that will amplify the role of Laguna recovery coaches in delivering a high level of whole person care for the sick. The model will accurately and instantly inform coaches of their patient’s needs and can provide treatment advice.

“Look around you and you can see that health systems are at a breaking point with overworked and exhausted providers. The integration of augmented intelligence into clinical care is the future of providing optimal patient care, ”said Gil Kaminski, Vice President of Clinical Products at Laguna Health.

“I am excited to be part of an elite team of physicians, behavioral health experts, product experts and engineers to create a model that will elevate and personalize care transitions. “

Kaminski’s career is rooted in technological R&D and clinical operations. Most recently she has worked with DaVita Kidney Care for five years where she was director of operations. She was responsible for more than 25 dialysis centers in the Greater Philadelphia region, serving 1,900 patients and managing 500 employees. Prior to joining DaVita, Kaminski was a consultant for various medical and tech companies and provided insight into entrepreneurship and innovation. Before consulting, she was an algorithm engineer for a sleep clinic company, WideMed Ltd. WideMed focuses on sleep monitoring, cardiovascular diagnostics and predicting hospital admissions. Kaminski has created artificial intelligence (AI), machine learning (ML) and SaMD (software as a medical device) products. Early in Kaminski’s career, she served in the Israel Defense Force (IDF)‘s Naval Medical Institute in clinical operations and clinical research capacity as a research officer / facility manager. She has researched medical devices, physiological signal testing, pharmaceuticals, genetic science, and occupational health.

“Gil’s experience is the perfect marriage of technology development and operational management of patient care,” said Yoni Shtein, CEO and co-founder of Laguna Health. “Gil is an important piece of the recovery puzzle that Laguna Health is solving. It will help bring our vision to life, provide better tools for our recovery coaches, and allow patients to recover easily.”

About Laguna Health
Laguna is a digitally-driven home recovery platform that leverages digital care and multidisciplinary clinicians to reduce costly readmissions and shorten recovery time. Laguna ensures successful post-hospital recovery by combining data, digital care tools and behavioral health interventions proven to dramatically reduce negative outcomes. From employers to healthcare plans and providers, the entire healthcare ecosystem now has the capacity to ensure that every patient recovers with confidence. To learn more about Laguna, visit www.lagunahealth.com

Media contact:
Kimberly dreisinger | 805-350-4421
Mariah borthwick | 347-764-7819
[email protected]

SOURCE Laguna Health


Source link

]]>